WO2008146796A1 - ５－メチル－１－フェニル－２－（１ｈ）－ピリドン含有貼付剤 - Google Patents

５－メチル－１－フェニル－２－（１ｈ）－ピリドン含有貼付剤 Download PDF

Info

Publication number
WO2008146796A1
WO2008146796A1 PCT/JP2008/059672 JP2008059672W WO2008146796A1 WO 2008146796 A1 WO2008146796 A1 WO 2008146796A1 JP 2008059672 W JP2008059672 W JP 2008059672W WO 2008146796 A1 WO2008146796 A1 WO 2008146796A1
Authority
WO
WIPO (PCT)
Prior art keywords
pyridone
phenyl
methyl
medicated patch
preparation layer
Prior art date
Application number
PCT/JP2008/059672
Other languages
English (en)
French (fr)
Inventor
Takayasu Matsuzawa
Tamaki Horiuchi
Seijiro Yama
Tetsukazu Hamamoto
Sunao Takeuchi
Daisuke Ichimatsu
Original Assignee
Lead Chemical Co., Ltd.
Shionogi & Co., Ltd.
Kdl Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lead Chemical Co., Ltd., Shionogi & Co., Ltd., Kdl Co., Ltd. filed Critical Lead Chemical Co., Ltd.
Priority to BRPI0810957A priority Critical patent/BRPI0810957A2/pt
Priority to CN200880100095A priority patent/CN101754757A/zh
Priority to US12/451,646 priority patent/US8287900B2/en
Publication of WO2008146796A1 publication Critical patent/WO2008146796A1/ja

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4418—Non condensed pyridines; Hydrogenated derivatives thereof having a carbocyclic group directly attached to the heterocyclic ring, e.g. cyproheptadine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/44—Medicaments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/204—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials with nitrogen-containing functional groups, e.g. aminoxides, nitriles, guanidines

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Hematology (AREA)
  • Materials Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Botany (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

【課題】５－メチル－１－フェニル－２－（１Ｈ）－ピリドン含有貼付剤を提供する。 【解決手段】経皮吸収製剤層を含有する貼付剤であって、 　該経皮吸収製剤層は、有効成分として５－メチル－１－フェニル－２－（１Ｈ）－ピリドン又はその医学的に許容できる塩類、溶解剤及び水性基剤（又はゴム系基剤）を含有し、かつ該有効成分を、経皮吸収製剤層の総量に基づき、０．１～３０質量％含有することを特徴とする貼付剤。
PCT/JP2008/059672 2007-05-25 2008-05-26 ５－メチル－１－フェニル－２－（１ｈ）－ピリドン含有貼付剤 WO2008146796A1 (ja)

Priority Applications (3)

Application Number Priority Date Filing Date Title
BRPI0810957A BRPI0810957A2 (pt) 2007-05-25 2008-05-26 "emplasto medicamentoso compreendendo 5-metila-1-fenila-2-(1h) piridona".
CN200880100095A CN101754757A (zh) 2007-05-25 2008-05-26 含5-甲基-1-苯基-2-(1h)-吡啶酮的粘贴剂
US12/451,646 US8287900B2 (en) 2007-05-25 2008-05-26 Medicated patch comprising 5-methyl-1-phenyl-2-(1H)-pyridone

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2007-139653 2007-05-25
JP2007139653A JP5248040B2 (ja) 2007-05-25 2007-05-25 ５−メチル−１−フェニル−２−（１ｈ）−ピリドン含有貼付剤

Publications (1)

Publication Number Publication Date
WO2008146796A1 true WO2008146796A1 (ja) 2008-12-04

Family

ID=40075036

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2008/059672 WO2008146796A1 (ja) 2007-05-25 2008-05-26 ５－メチル－１－フェニル－２－（１ｈ）－ピリドン含有貼付剤

Country Status (6)

Country Link
US (1) US8287900B2 (ja)
JP (1) JP5248040B2 (ja)
KR (1) KR20100027139A (ja)
CN (1) CN101754757A (ja)
BR (1) BRPI0810957A2 (ja)
WO (1) WO2008146796A1 (ja)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2011525B1 (en) * 2007-07-05 2011-05-04 Nitto Denko Corporation Patch and patch preparation
EP2359827A1 (en) * 2008-11-21 2011-08-24 Lead Chemical Co. Ltd. Adhesive material containing 5-methyl-1-phenyl-2-(1h)-pyridone
WO2012105620A1 (ja) * 2011-02-02 2012-08-09 日東電工株式会社 貼付剤および貼付製剤
WO2012105619A1 (ja) * 2011-02-02 2012-08-09 日東電工株式会社 貼付剤および貼付製剤
WO2015020153A1 (ja) * 2013-08-09 2015-02-12 帝國製薬株式会社 ベラプロスト含有貼付剤

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080210265A1 (en) 2007-03-01 2008-09-04 Crawford Charles A Coating removal composition
US20130226112A1 (en) * 2010-09-03 2013-08-29 Medrx Co., Ltd. Percutaneous absorbent and adhesive sheet for skin patch
EA026621B1 (ru) 2012-05-28 2017-04-28 Аббекс Аб Композиция для лечения бородавок
CN105250995B (zh) * 2013-09-25 2018-06-22 河南汇博医疗股份有限公司 增生性疤痕修复贴膜及其制备方法
WO2018204523A1 (en) * 2017-05-03 2018-11-08 Kuefner George C Systems and methods for treating skin conditions with magnesium ion compositions
KR20220051135A (ko) 2019-05-13 2022-04-26 바이오 메드 사이언시즈, 인크. 활성 성분 상처케어, 및 이의 흉터 관리 제품, 제조 방법 및 유용한 물품
WO2021022033A1 (en) 2019-07-30 2021-02-04 Leung Kai P Layered composite for scar treatment and prevention

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004203795A (ja) * 2002-12-26 2004-07-22 Kdl Inc ピリドン誘導体の溶液状医薬組成物
WO2004073680A1 (ja) * 2003-02-21 2004-09-02 Shionogi & Co., Ltd. 液滴分散型軟膏剤
WO2004073713A1 (ja) * 2003-02-21 2004-09-02 Shionogi & Co., Ltd. ピルフェニドンのゲル剤
JP2006298774A (ja) * 2005-04-15 2006-11-02 Lead Chemical Co Ltd 経皮吸収型フリーラジカル抑制製剤

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1248450A (en) * 1984-04-05 1989-01-10 Kazuo Kigasawa Soft patch
US5167649A (en) * 1988-08-22 1992-12-01 Zook Gerald P Drug delivery system for the removal of dermal lesions
JP2002526447A (ja) * 1998-09-18 2002-08-20 メファ・アクチェンゲゼルシャフト アルキルフェニルピリドンの局所製剤
US7867516B2 (en) 2001-01-29 2011-01-11 Shionogi & Co., Ltd. Medicinal preparation containing 5-methyl-1-phenyl-2-(1h)-pyridone as active ingredient
EP1559426B1 (en) * 2002-11-05 2011-02-09 Lead Chemical Co. Ltd. Percutaneous absorption preparations containing 3-methyl-1-phenyl-2-pyrazolin-5-one

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004203795A (ja) * 2002-12-26 2004-07-22 Kdl Inc ピリドン誘導体の溶液状医薬組成物
WO2004073680A1 (ja) * 2003-02-21 2004-09-02 Shionogi & Co., Ltd. 液滴分散型軟膏剤
WO2004073713A1 (ja) * 2003-02-21 2004-09-02 Shionogi & Co., Ltd. ピルフェニドンのゲル剤
JP2006298774A (ja) * 2005-04-15 2006-11-02 Lead Chemical Co Ltd 経皮吸収型フリーラジカル抑制製剤

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2011525B1 (en) * 2007-07-05 2011-05-04 Nitto Denko Corporation Patch and patch preparation
EP2359827A1 (en) * 2008-11-21 2011-08-24 Lead Chemical Co. Ltd. Adhesive material containing 5-methyl-1-phenyl-2-(1h)-pyridone
EP2359827A4 (en) * 2008-11-21 2013-01-02 Lead Chem Co Ltd ADHESIVE MATERIAL CONTAINING 5-METHYL-1-PHENYL-2- (1H) -PYRIDONE
WO2012105620A1 (ja) * 2011-02-02 2012-08-09 日東電工株式会社 貼付剤および貼付製剤
WO2012105619A1 (ja) * 2011-02-02 2012-08-09 日東電工株式会社 貼付剤および貼付製剤
JP2012158571A (ja) * 2011-02-02 2012-08-23 Nitto Denko Corp 貼付剤および貼付製剤
US9351942B2 (en) 2011-02-02 2016-05-31 Nitto Denko Corporation Patch and patch preparation
US9808609B2 (en) 2011-02-02 2017-11-07 Nitto Denko Corporation Patch and patch preparation
WO2015020153A1 (ja) * 2013-08-09 2015-02-12 帝國製薬株式会社 ベラプロスト含有貼付剤
JPWO2015020153A1 (ja) * 2013-08-09 2017-03-02 帝國製薬株式会社 ベラプロスト含有貼付剤
US10335389B2 (en) 2013-08-09 2019-07-02 Teikoku Seiyaku Co., Ltd. Beraprost-containing patch

Also Published As

Publication number Publication date
US20100119584A1 (en) 2010-05-13
KR20100027139A (ko) 2010-03-10
JP5248040B2 (ja) 2013-07-31
BRPI0810957A2 (pt) 2019-01-08
CN101754757A (zh) 2010-06-23
JP2008290984A (ja) 2008-12-04
US8287900B2 (en) 2012-10-16

Similar Documents

Publication Publication Date Title
WO2008146796A1 (ja) ５－メチル－１－フェニル－２－（１ｈ）－ピリドン含有貼付剤
WO2009066457A1 (ja) 脂肪酸系イオン液体を有効成分とする外用剤組成物
WO2007009806A3 (en) Solid dosage formulations of narcotic drugs having improved buccal adsorption
IL180887A0 (en) Quinoline derivatives and insecticide comprising thereof as active ingredient
WO2010150995A3 (en) Compositions for treating drug addiction and improving addiction-related behavior
IL216704A (en) Micronutrients containing dictopiperazine salts and biologically active substance and used in the preparation of preparations for providing the active substance
WO2007047948A3 (en) Intranasal administration of rapid acting insulin
WO2007021666A3 (en) Liquid formulations
AU2003274681A1 (en) Dosage form comprising high dose high soluble active ingredient as modified release and low dose active ingredient as immediate release
WO2006044421A3 (en) Cardiac safe, rapid medication delivery
UA98799C2 (ru) Твердый препарат, включающий алоглиптин и гидрохлорид метформина
WO2004056363A3 (en) A physically and chemically stable nicotine-containing particulate material
IL198411A0 (en) Haloalkylsulfonanilide derivative or salt thereof, herbicide comprising the derivative as active ingredient, and use of the herbicide
TW200735870A (en) Pharmaceutical formulations comprising a long-acting beta2-agonist for administration by nebulisation
WO2005092304A3 (en) Antifungal agents
WO2008150085A3 (en) 3',4',5-trimethoxy flavone derivatives as stimulant of mucus secretion, method of the same, and pharmaceutical composition comprising the same
EP2196206B8 (en) Remedy for relieving skin troubles comprising morphinan derivative or pharmacologically acceptable acid addition salt thereof as the active ingredient
SI1954251T1 (sl) Sestavek s počasnim sproščanjem, ki ima kot aktivno učinkovino Fe sol, postopek njegove priprave in uporabe
WO2008116601A3 (en) Solid dosage forms comprising aliskiren and pharmaceutically acceptable salts thereof
MX2010007281A (es) Composiciones farmaceuticas de amlodipina y valsartan.
NO20055601D0 (no) Farmasoytisk preparat i form av en hydrogel for transdermal administrasjon av aktive virkestoffer
WO2009100101A3 (en) Solid formulation of low melting active compound
GEP20156410B (en) Formulation comprising phenylaminopyrimidine derivative as active agent
WO2005120518A3 (en) Use of atp analogues for treatment of cardiovascular diseases
WO2009084041A3 (en) Pharmaceutical compositions of dexibuprofen

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 200880100095.7

Country of ref document: CN

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08764705

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

ENP Entry into the national phase

Ref document number: 20097026380

Country of ref document: KR

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 8482/DELNP/2009

Country of ref document: IN

WWE Wipo information: entry into national phase

Ref document number: 12451646

Country of ref document: US

122 Ep: pct application non-entry in european phase

Ref document number: 08764705

Country of ref document: EP

Kind code of ref document: A1

ENPW Started to enter national phase and was withdrawn or failed for other reasons

Ref document number: PI0810957

Country of ref document: BR

Free format text: PEDIDO CONSIDERADO RETIRADO EM RELACAO AO BRASIL POR NAO ATENDER O ART.6O DA RESOLUCAO 77/2013.

ENP Entry into the national phase

Ref document number: PI0810957

Country of ref document: BR

Kind code of ref document: A2

Effective date: 20091123